Target intelligence / Profile preview

CD4 T cell receptor complex (TCR-CD4 complex)

Target
TCR-CD4 complex
Molecular classification
Receptor (T cell receptor, CD4), Costimulatory molecule (CD28), Other (immune cell surface molecule, coreceptor)
01

Overview

Activation of CD4+ helper T lymphocytes describes the process whereby naive CD4+ T cells are triggered through engagement of their T cell receptor (TCR) with antigen presented via major histocompatibility complex II (MHC-II) on antigen-presenting cells, together with costimulatory signals such as CD28 engagement and a cytokine milieu that directs differentiation[1][2][5][6][7]. This activation leads to proliferation and differentiation of CD4+ T cells into various subsets (Th1, Th2, Th17, Tfh, Treg, etc.), each orchestrating distinct arms of the immune response through cytokine production, B cell help, and regulation of cytotoxic T cell responses[5][7]. Co-inhibitory molecules, metabolic switches, and finely tuned intracellular signaling cascades regulate the magnitude and quality of the response, and dysregulation at any step can contribute to autoimmunity, immune deficiency, or cancer[1][2][6][7].

Other names
CD4+ T cell activationCD4+ lymphocyte activationT helper cell activation
02

Mechanism of action

Inhibition of costimulatory signaling (e.g., abatacept); Suppression of T cell receptor signal transduction (e.g., calcineurin inhibitors block NFAT signaling); Depletion or modulation of T cells (anti-CD3 therapy)

03

Biological functions

Immune responseSignal transductionCell proliferationCell differentiationCytokine production
04

Disease associations

Autoimmune diseaseInfectionCancer (immunotherapy target)Inflammation
05

Safety considerations

Immunosuppression (increased risk of infection, malignancy)Cytokine release syndrome (excessive T cell activation)Loss of immune tolerance (autoimmune reactions)
06

Interacting drugs

Abatacept

3 more in the full profile.

07

Biomarkers

CD69 (early activation marker)CD25 (IL-2 receptor alpha)Intracellular cytokines (e.g., IFN-γ, IL-2)Surface expression of CD40L (CD154)

Beyond the preview

Go deeper on CD4 T cell receptor complex (TCR-CD4 complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD4 T cell receptor complex (TCR-CD4 complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call